PATENT CLAIM ANALYSIS

Application Number: 15860356
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "377000"]

Abstract:
The disclosure provides methods and compositions useful for obtaining induced stem cells, methods of making and use thereof.

Claim (Index 7):
The method of  claim 1 , wherein the polynucleotide encoding the KLF4 polypeptide encodes a KLF4 polypeptide selected from the group consisting of:\n (a) a polypeptide having a sequence that has at least 95% sequence identity to the sequence of SEQ ID NO:8 and having KLF activity; and (b) a polypeptide having the sequence as set forth in SEQ ID NO:8.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.11111
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14402924', '13088009', '12743776', '13590880', '14311545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7009013880374938
- 35 USC 102 Novelty (BERT): 0.750559640106346
- Combined Prediction Score: 0.7058672132443791
- Mean Citation Score: 540.3153980000002
- Max Citation Score: 1017.5787
- Similarity Product: 858.2564459508418

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test